01—Abstract
Summary
Summary of the 10-K/A filed August 4, 2014. Cited figures are marked; the original filing is the authoritative source.
This 10-K filing for Altria Group, Inc. (MO) covers the fiscal year ending December 30, 2013, and was amended and filed on August 3, 2014.
The filing primarily consists of amendments to previously submitted information and the incorporation by reference of SABMiller Financial Statements. While the specific details of the operational performance and financial results for Altria are not explicitly detailed within this amendment itself (as it focuses on exhibits), investors should note that this filing incorporates by reference significant financial data from SABMiller, suggesting a strategic relationship or investment interest in that entity. Investors should refer to the primary 10-K filing for the detailed financial performance and management's discussion and analysis of Altria's core business operations, including its tobacco segments.
02—Key points
Key Highlights
- The filing is an amendment (10-K/A) to the original 2013 annual report, indicating revisions or additions to previously disclosed information.
- Key financial statements from SABMiller are incorporated by reference, highlighting a significant connection or investment involving Altria and SABMiller.
- The amendment includes standard exhibits such as the Consent of Independent Accountants.
- Investors will need to consult the original 10-K filing for comprehensive details on Altria's operational performance and financial condition for the fiscal year 2013.
- The filing date of August 3, 2014, suggests that the original 10-K was likely filed earlier in 2014.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2013, Altria Group, Inc. kept $0.19.
- Revenue$24.47B100.0%
- Cost of revenue−$14.01B57.3%
- Gross profit$10.46B42.7%
- Operating costs−$2.37B9.7%
- Operating income$8.08B33.0%
- Interest, other & tax−$3.55B14.5%
- Net income$4.54B18.5%
Where FY2013 revenue went
$24.47B- Other operating costs: $9.02B, 37% of revenue
- Cost of revenue: $7.21B, 29% of revenue
- Net income: $4.54B, 19% of revenue
- Interest, other & tax: $3.55B, 15% of revenue
- R&D: $153.0M, 0.6% of revenue
Kept 19% as net income
Full revenue history →04—Financials
Financial Highlights
Figures from 10-K/AFY2013filed August 4, 2014Financial Statements
FY2013 against FY2012
| Line item | FY2013FY2012 | Change |
|---|---|---|
| Revenue | $24.47B$24.62B | −0.6% |
| Cost of Revenue | $7.21B$7.94B | −9.2% |
| Gross Profit | $10.46B$9.56B | +9.3% |
| R&D Expenses | $153.00M$136.00M | +12.5% |
| Operating Income | $8.08B$7.25B | +11.5% |
| Interest Expense | $1.05B$1.13B | −6.6% |
| Net Income | $4.54B$4.18B | +8.4% |
| EPS (Basic) | $2.26$2.06 | +9.7% |
| Shares Outstanding (Basic) | 2.00B2.02B | −1.2% |
05—Questions
Frequently Asked Questions
What is the primary purpose of this 10-K/A filing?
This filing is an amendment (10-K/A) to Altria Group, Inc.'s original 2013 Annual Report. It primarily serves to incorporate by reference the financial statements of SABMiller and to include necessary exhibits, such as the consent of independent accountants. It does not contain the full operational and financial review of Altria's core business.
What is the significance of the SABMiller Financial Statements being incorporated?
The incorporation of SABMiller's financial statements suggests a material relationship, such as a significant investment or strategic partnership, between Altria and SABMiller. Investors should investigate the nature of this relationship to understand its potential impact on Altria's overall financial picture and future strategy.
Where can I find the detailed financial results and management's discussion for Altria's 2013 performance?
This amendment focuses on exhibits and specific incorporated statements. For a comprehensive understanding of Altria's operational performance, financial results, and management's analysis for the fiscal year ended December 30, 2013, investors should refer to the original 10-K filing made by Altria Group, Inc.
06—Continue